87 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Luban J, Sattler R, Mühlberger E, Graci JD, Cao L, Weetall M, Trotta C, Colacino JM, Bavari S, Strambio-De-Castillia C, Suder EL, Wang Y, Soloveva V, Cintron-Lue K, Naryshkin NA, ... ... Peltz S, et al. The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines. Virus Research. 198246. PMID 33249060 DOI: 10.1016/j.virusres.2020.198246  1
2020 Luban J, Sattler R, Mühlberger E, Graci JD, Cao L, Weetall M, Trotta C, Colacino JM, Bavari S, Strambio-De-Castillia C, Suder EL, Wang Y, Soloveva V, Cintron-Lue K, Naryshkin NA, ... ... Peltz S, et al. The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines. Biorxiv : the Preprint Server For Biology. PMID 32793904 DOI: 10.1101/2020.08.05.238394  1
2018 Friesen WJ, Johnson B, Sierra J, Zhuo J, Vazirani P, Xue X, Tomizawa Y, Baiazitov R, Morrill C, Ren H, Babu S, Moon YC, Branstrom A, Mollin A, Hedrick J, ... ... Peltz SW, et al. The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential. Plos One. 13: e0206158. PMID 30359426 DOI: 10.1371/Journal.Pone.0206158  0.52
2018 Cao L, Weetall M, Trotta C, Cintron K, Ma J, Kim MJ, Furia B, Romfo C, Graci JD, Li W, Du J, Sheedy J, Hedrick J, Risher N, Yeh S, ... ... Peltz SW, et al. Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties. Molecular Cancer Therapeutics. PMID 30352802 DOI: 10.1158/1535-7163.Mct-18-0863  1
2017 Friesen WJ, Trotta CR, Tomizawa Y, Zhuo J, Johnson B, Sierra J, Roy B, Weetall M, Hedrick J, Sheedy J, Takasugi J, Moon YC, Babu S, Baiazitov R, Leszyk JD, ... ... Peltz SW, et al. The nucleoside analog clitocine is a potent and efficacious readthrough agent. Rna (New York, N.Y.). PMID 28096517 DOI: 10.1261/Rna.060236.116  0.52
2016 Weetall M, Davis T, Elfring G, Northcutt V, Cao L, Moon YC, Riebling P, Dali M, Hirawat S, Babiak J, Colacino J, Almstead N, Spiegel R, Peltz SW. Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation. Clinical Pharmacology in Drug Development. 5: 296-305. PMID 27310330 DOI: 10.1002/cpdd.240  0.4
2016 Weetall M, Davis T, Elfring G, Northcutt V, Cao L, Moon YC, Riebling P, Dali M, Hirawat S, Babiak J, Colacino J, Almstead N, Spiegel R, Peltz SW. Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation Clinical Pharmacology in Drug Development. DOI: 10.1002/cpdd.240  0.4
2014 Naryshkin NA, Weetall M, Dakka A, Narasimhan J, Zhao X, Feng Z, Ling KK, Karp GM, Qi H, Woll MG, Chen G, Zhang N, Gabbeta V, Vazirani P, Bhattacharyya A, ... ... Peltz SW, et al. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science (New York, N.Y.). 345: 688-93. PMID 25104390 DOI: 10.1126/Science.1250127  1
2014 Bushby K, Finkel R, Wong B, Barohn R, Campbell C, Comi GP, Connolly AM, Day JW, Flanigan KM, Goemans N, Jones KJ, Mercuri E, Quinlivan R, Renfroe JB, Russman B, ... ... Peltz SW, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle & Nerve. 50: 477-87. PMID 25042182 DOI: 10.1002/Mus.24332  1
2014 Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, ... ... Peltz SW, et al. Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. Respiratory Medicine. 2: 539-47. PMID 24836205 DOI: 10.1016/S2213-2600(14)70100-6  1
2013 Finkel RS, Flanigan KM, Wong B, Bönnemann C, Sampson J, Sweeney HL, Reha A, Northcutt VJ, Elfring G, Barth J, Peltz SW. Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy. Plos One. 8: e81302. PMID 24349052 DOI: 10.1371/journal.pone.0081302  1
2013 McDonald CM, Henricson EK, Abresch RT, Florence JM, Eagle M, Gappmaier E, Glanzman AM, Spiegel R, Barth J, Elfring G, Reha A, Peltz S. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle & Nerve. 48: 343-56. PMID 23681930 DOI: 10.1002/mus.23902  1
2013 McDonald CM, Henricson EK, Abresch RT, Florence J, Eagle M, Gappmaier E, Glanzman AM, Spiegel R, Barth J, Elfring G, Reha A, Peltz SW. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle & Nerve. 48: 357-68. PMID 23674289 DOI: 10.1002/mus.23905  1
2013 Gu Z, Graci JD, Lahser FC, Breslin JJ, Jung SP, Crona JH, McMonagle P, Xia E, Liu S, Karp G, Zhu J, Huang S, Nomeir A, Weetall M, Almstead NG, ... Peltz SW, et al. Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein. Antimicrobial Agents and Chemotherapy. 57: 3250-61. PMID 23629699 DOI: 10.1128/Aac.00527-13  1
2013 Peltz SW, Morsy M, Welch EM, Jacobson A. Ataluren as an agent for therapeutic nonsense suppression. Annual Review of Medicine. 64: 407-25. PMID 23215857 DOI: 10.1146/annurev-med-120611-144851  1
2011 Micheva-Viteva S, Kobayashi Y, Edelstein LC, Pacchia AL, Lee HL, Graci JD, Breslin J, Phelan BD, Miller LK, Colacino JM, Gu Z, Ron Y, Peltz SW, Dougherty JP. High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor. The Journal of Biological Chemistry. 286: 21083-91. PMID 21498519 DOI: 10.1074/Jbc.M110.195537  1
2011 Kerem E, Wilschanski M, Miller NL, Pugatsch T, Cohen T, Blau H, Rivlin J, Shoseyov D, Reha A, Constantine S, Ajayi T, Hirawat S, Elfring GL, Peltz SW, Miller LL. Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: 193-200. PMID 21459051 DOI: 10.1016/J.Jcf.2011.02.003  1
2010 Wang B, Yang Z, Brisson BK, Feng H, Zhang Z, Welch EM, Peltz SW, Barton ER, Brown RH, Sweeney HL. Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression. Journal of Applied Physiology (Bethesda, Md. : 1985). 109: 901-5. PMID 20558759 DOI: 10.1152/Japplphysiol.01366.2009  1
2009 Peltz SW, Welch EM, Trotta CR, Davis T, Jacobson A. Targeting post-transcriptional control for drug discovery. Rna Biology. 6: 329-34. PMID 19574739  1
2009 Peltz SW, Welch EM, Jacobson A, Trotta CR, Naryshkin N, Sweeney HL, Bedwell DM. Nonsense suppression activity of PTC124 (ataluren). Proceedings of the National Academy of Sciences of the United States of America. 106: E64; author reply E6. PMID 19506240 DOI: 10.1073/Pnas.0901936106  1
2009 Graci JD, Colacino JM, Peltz SW, Dougherty JP, Gu Z. HIV type-1 latency: targeted induction of proviral reservoirs. Antiviral Chemistry & Chemotherapy. 19: 177-87. PMID 19483266 DOI: 10.1177/095632020901900501  1
2009 Kerem E, Kerem B, Welch EM, Trotta C, Weetall M, Miller L, Jacobson A, Peltz SW. PTC124 for cystic fibrosis - Authors' reply The Lancet. 373: 1426-1427. PMID 19394530 DOI: 10.1016/S0140-6736(09)60820-5  1
2009 Hossain MA, Peltz SW. Eukaryotic release factor 1 affects +1 and -1 ribosomal frameshifting in HeLa cells International Journal of Biological Chemistry. 3: 35-41. DOI: 10.3923/ijbc.2009.35.41  1
2008 Du M, Liu X, Welch EM, Hirawat S, Peltz SW, Bedwell DM. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proceedings of the National Academy of Sciences of the United States of America. 105: 2064-9. PMID 18272502 DOI: 10.1073/Pnas.0711795105  1
2007 Bhattacharyya A, Trotta CR, Peltz SW. Mining the GEMS--a novel platform technology targeting post-transcriptional control mechanisms. Drug Discovery Today. 12: 553-60. PMID 17631250 DOI: 10.1016/j.drudis.2007.05.009  0.4
2007 Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, Wilde RG, Karp G, Takasugi J, Chen G, Jones S, ... ... Peltz SW, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature. 447: 87-91. PMID 17450125 DOI: 10.1038/Nature05756  1
2007 Hirawat S, Welch EM, Elfring GL, Northcutt VJ, Paushkin S, Hwang S, Leonard EM, Almstead NG, Ju W, Peltz SW, Miller LL. Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers. Journal of Clinical Pharmacology. 47: 430-44. PMID 17389552 DOI: 10.1177/0091270006297140  0.52
2006 Trotta CR, Paushkin SV, Patel M, Li H, Peltz SW. Cleavage of pre-tRNAs by the splicing endonuclease requires a composite active site. Nature. 441: 375-7. PMID 16710424 DOI: 10.1038/nature04741  0.4
2006 Wang W, Cajigas IJ, Peltz SW, Wilkinson MF, González CI. Role for Upf2p phosphorylation in Saccharomyces cerevisiae nonsense-mediated mRNA decay. Molecular and Cellular Biology. 26: 3390-400. PMID 16611983 DOI: 10.1128/Mcb.26.9.3390-3400.2006  1
2006 Mehta A, Trotta CR, Peltz SW. Derepression of the Her-2 uORF is mediated by a novel post-transcriptional control mechanism in cancer cells. Genes & Development. 20: 939-53. PMID 16598037 DOI: 10.1101/gad.1388706  0.4
2005 Micheva-Viteva S, Pacchia AL, Ron Y, Peltz SW, Dougherty JP. Human immunodeficiency virus type 1 latency model for high-throughput screening. Antimicrobial Agents and Chemotherapy. 49: 5185-8. PMID 16304201 DOI: 10.1128/AAC.49.12.5185-5188.2005  1
2005 Duttagupta R, Tian B, Wilusz CJ, Khounh DT, Soteropoulos P, Ouyang M, Dougherty JP, Peltz SW. Global analysis of Pub1p targets reveals a coordinate control of gene expression through modulation of binding and stability. Molecular and Cellular Biology. 25: 5499-513. PMID 15964806 DOI: 10.1128/Mcb.25.13.5499-5513.2005  1
2005 Le Roy F, Salehzada T, Bisbal C, Dougherty JP, Peltz SW. A newly discovered function for RNase L in regulating translation termination Nature Structural and Molecular Biology. 12: 505-512. PMID 15908960 DOI: 10.1038/nsmb944  1
2004 Weetall M, Cao L, Moon YC, Davis T, Hirawat S, Colacino J, Almstead N, Babiak J, Miller L, Peltz S. Low molecular weight (LMW) orally bioavailable inhibitors of tumor vascular endothelial growth factor (VEGF) translation delay tumor growth in vivo: A new approach to inhibition of angiogenesis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3123. PMID 28014870 DOI: 10.1200/jco.2004.22.14_suppl.3123  0.4
2004 Paushkin SV, Patel M, Furia BS, Peltz SW, Trotta CR. Identification of a human endonuclease complex reveals a link between tRNA splicing and pre-mRNA 3' end formation. Cell. 117: 311-21. PMID 15109492  0.4
2004 Biswas P, Jiang X, Pacchia AL, Dougherty JP, Peltz SW. The Human Immunodeficiency Virus Type 1 Ribosomal Frameshifting Site Is an Invariant Sequence Determinant and an Important Target for Antiviral Therapy Journal of Virology. 78: 2082-2087. PMID 14747573 DOI: 10.1128/JVI.78.4.2082-2087.2004  1
2003 Vasudevan S, Peltz SW. Nuclear mRNA surveillance. Current Opinion in Cell Biology. 15: 332-7. PMID 12787776 DOI: 10.1016/S0955-0674(03)00051-6  1
2003 Duttagupta R, Vasudevan S, Wilusz CJ, Peltz SW. A yeast homologue of Hsp70, Ssa1p, regulates turnover of the MFA2 transcript through its AU-rich 3' untranslated region. Molecular and Cellular Biology. 23: 2623-32. PMID 12665566 DOI: 10.1128/Mcb.23.8.2623-2632.2003  1
2003 Adelson ME, Pacchia AL, Kaul M, Rando RF, Ron Y, Peltz SW, Dougherty JP. Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy. 47: 501-8. PMID 12543650 DOI: 10.1128/AAC.47.2.501-508.2003  1
2002 Vasudevan S, Peltz SW, Wilusz CJ. Non-stop decay--a new mRNA surveillance pathway. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 24: 785-8. PMID 12210514 DOI: 10.1002/Bies.10153  1
2001 Wilusz CJ, Wang W, Peltz SW. Curbing the nonsense: The activation and regulation of mRNA surveillance Genes and Development. 15: 2781-2785. PMID 11691829 DOI: 10.1101/Gad.943701  1
2001 Vasudevan S, Peltz SW. Regulated ARE-mediated mRNA decay in Saccharomyces cerevisiae Molecular Cell. 7: 1191-1200. PMID 11430822 DOI: 10.1016/S1097-2765(01)00279-9  1
2001 Ruiz-Echevarria MJ, Munshi R, Tomback J, Kinzy TG, Peltz SW. Characterization of a general stabilizer element that blocks deadenylation-dependent mRNA decay. The Journal of Biological Chemistry. 276: 30995-1003. PMID 11423548 DOI: 10.1074/Jbc.M010833200  1
2001 Wilusz CJ, Wormington M, Peltz SW. The cap-to-tail guide to mRNA turnover Nature Reviews Molecular Cell Biology. 2: 237-246. PMID 11283721 DOI: 10.1038/35067025  1
2001 Gao M, Wilusz CJ, Peltz SW, Wilusz J. A novel mRNA-decapping activity in HeLa cytoplasmic extracts is regulated by AU-rich elements Embo Journal. 20: 1134-1143. PMID 11230136 DOI: 10.1093/Emboj/20.5.1134  1
2001 Wang W, Czaplinski K, Rao Y, Peltz SW. The role of Upf proteins in modulating the translation read-through of nonsense-containing transcripts Embo Journal. 20: 880-890. PMID 11179232 DOI: 10.1093/emboj/20.4.880  1
2000 Bhattacharya A, Czaplinski K, Trifillis P, He F, Jacobson A, Peltz SW. Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense-mediated mRNA decay Rna. 6: 1226-1235. PMID 10999600 DOI: 10.1017/S1355838200000546  1
2000 Ruiz-Echevarría MJ, Peltz SW. The RNA binding protein Pub1 modulates the stability of transcripts containing upstream open reading frames. Cell. 101: 741-51. PMID 10892745 DOI: 10.1016/S0092-8674(00)80886-7  0.48
2000 González CI, Ruiz-Echevarría MJ, Vasudevan S, Henry MF, Peltz SW. The yeast hnRNP-like protein Hrp1/Nab4 marks a transcript for nonsense-mediated mRNA decay. Molecular Cell. 5: 489-99. PMID 10882134 DOI: 10.1016/S1097-2765(00)80443-8  0.48
2000 Czaplinski K, Majlesi N, Banerjee T, Peltz SW. Mtt1 is a Upf1-like helicase that interacts with the translation termination factors and whose overexpression can modulate termination efficiency Rna. 6: 730-743. PMID 10836794 DOI: 10.1017/S1355838200992392  1
1999 Peltz SW, Dougherty JP. Antisense translates into sense Journal of Experimental Medicine. 190: 1729-1731. PMID 10601348 DOI: 10.1084/jem.190.12.1729  1
1999 Czaplinski K, Ruiz-Echevarria MJ, González CI, Peltz SW. Should we kill the messenger? The role of the surveillance complex in translation termination and mRNA turnover. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 21: 685-96. PMID 10440865 DOI: 10.1002/(Sici)1521-1878(199908)21:8<685::Aid-Bies8>3.0.Co;2-4  1
1999 Cui Y, González CI, Kinzy TG, Dinman JD, Peltz SW. Mutations in the MOF2/SUI1 gene affect both translation and nonsense- mediated mRNA decay Rna. 5: 794-804. PMID 10376878 DOI: 10.1017/S1355838299982055  1
1999 Sheikh MS, Fernandez-Salas E, Yu M, Hussain A, Dinman JD, Peltz SW, Huang Y, Fornace AJ. Cloning and characterization of a human genotoxic and endoplasmic reticulum stress-inducible cDNA that encodes translation initiation factor 1(eIF1(A121/SUI1)) Journal of Biological Chemistry. 274: 16487-16493. PMID 10347211 DOI: 10.1074/jbc.274.23.16487  1
1999 Hammell AB, Taylor RC, Peltz SW, Dinman JD. Identification of putative programmed -1 ribosomal frameshift signals in large DNA databases. Genome Research. 9: 417-27. PMID 10330121  1
1999 Jacobson A, Peltz SW. Tools for turnover: methods for analysis of mRNA stability in eukaryotic cells. Methods (San Diego, Calif.). 17: 1-2. PMID 10075876 DOI: 10.1006/METH.1998.0700  0.48
1999 Peltz SW, Hammell AB, Cui Y, Yasenchak J, Puljanowski L, Dinman JD. Ribosomal protein L3 mutants alter translational fidelity and promote rapid loss of the yeast killer virus Molecular and Cellular Biology. 19: 384-391. PMID 9858562  1
1998 Ruiz-Echevarría MJ, Yasenchak JM, Han X, Dinman JD, Peltz SW. The upf3 protein is a component of the surveillance complex that monitors both translation and mRNA turnover and affects viral propagation. Proceedings of the National Academy of Sciences of the United States of America. 95: 8721-6. PMID 9671745 DOI: 10.1073/Pnas.95.15.8721  1
1998 Czaplinski K, Ruiz-Echevarria MJ, Paushkin SV, Han X, Weng Y, Perlick HA, Dietz HC, Ter-Avanesyan MD, Peltz SW. The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes & Development. 12: 1665-77. PMID 9620853 DOI: 10.1101/Gad.12.11.1665  1
1998 Dinman JD, Ruiz-Echevarria MJ, Peltz SW. Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents. Trends in Biotechnology. 16: 190-6. PMID 9586242 DOI: 10.1016/S0167-7799(97)01167-0  1
1998 Cui Y, Dinman JD, Kinzy TG, Peltz SW. The Mof2/Sui1 protein is a general monitor of translational accuracy Molecular and Cellular Biology. 18: 1506-1516. PMID 9488467  1
1998 Ruiz-Echevarría MJ, González CI, Peltz SW. Identifying the right stop: determining how the surveillance complex recognizes and degrades an aberrant mRNA. The Embo Journal. 17: 575-89. PMID 9430648 DOI: 10.1093/emboj/17.2.575  0.48
1997 Dinman JD, Ruiz-Echevarria MJ, Czaplinski K, Peltz SW. Peptidyl-transferase inhibitors have antiviral properties by altering programmed -1 ribosomal frameshifting efficiencies: development of model systems. Proceedings of the National Academy of Sciences of the United States of America. 94: 6606-11. PMID 9192612 DOI: 10.1073/Pnas.94.13.6606  1
1996 Ruiz-Echevarria MJ, Czaplinski K, Peltz SW. Making sense of nonsense in yeast. Trends in Biochemical Sciences. 21: 433-8. PMID 8987399 DOI: 10.1016/S0968-0004(96)10055-4  1
1996 Cui Y, Dinman JD, Peltz SW. mof4-1 is an allele of the UPF1/IFS2 gene which affects both mRNA turnover and -1 ribosomal frameshifting efficiency Embo Journal. 15: 5726-5736. PMID 8896465  1
1996 Weng Y, Czaplinski K, Peltz SW. Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover Molecular and Cellular Biology. 16: 5491-5506. PMID 8816462 DOI: 10.1128/MCB.16.10.5491  1
1996 Weng Y, Czaplinski K, Peltz SW. Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein Molecular and Cellular Biology. 16: 5477-5490. PMID 8816461 DOI: 10.1128/MCB.16.10.5477  1
1996 Jacobson A, Peltz SW. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annual Review of Biochemistry. 65: 693-739. PMID 8811193 DOI: 10.1146/ANNUREV.BI.65.070196.003401  0.6
1996 Ruiz-Echevarria MJ, Peltz SW. Utilizing the GCN4 leader region to investigate the role of the sequence determinants in nonsense-mediated mRNA decay. The Embo Journal. 15: 2810-2819. DOI: 10.1002/j.1460-2075.1996.tb00641.x  0.36
1995 Zhang S, Ruiz-Echevarria MJ, Quan Y, Peltz SW. Identification and characterization of a sequence motif involved in nonsense-mediated mRNA decay. Molecular and Cellular Biology. 15: 2231-44. PMID 7891717 DOI: 10.1128/Mcb.15.4.2231  1
1995 Hagan KW, Ruiz-Echevarria MJ, Quan Y, Peltz SW. Characterization of cis-acting sequences and decay intermediates involved in nonsense-mediated mRNA turnover. Molecular and Cellular Biology. 15: 809-23. PMID 7823948 DOI: 10.1128/Mcb.15.2.809  1
1994 Peltz SW, He F, Welch E, Jacobson A. Nonsense-mediated mRNA decay in yeast. Progress in Nucleic Acid Research and Molecular Biology. 47: 271-98. PMID 8016322 DOI: 10.1016/S0079-6603(08)60254-8  0.36
1993 Peltz SW, Brown AH, Jacobson A. mRNA destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting factor. Genes & Development. 7: 1737-54. PMID 8370523 DOI: 10.1101/GAD.7.9.1737  1
1993 He F, Peltz SW, Donahue JL, Rosbash M, Jacobson A. Stabilization and ribosome association of unspliced pre-mRNAs in a yeast upf1- mutant. Proceedings of the National Academy of Sciences of the United States of America. 90: 7034-8. PMID 8346213 DOI: 10.1073/Pnas.90.15.7034  1
1993 Peltz SW, Jacobson A. mRNA stability: in trans-it. Current Opinion in Cell Biology. 4: 979-83. PMID 1485969 DOI: 10.1016/0955-0674(92)90129-Z  0.56
1992 Peltz SW, Donahue JL, Jacobson A. A mutation in the tRNA nucleotidyltransferase gene promotes stabilization of mRNAs in Saccharomyces cerevisiae Molecular and Cellular Biology. 12: 5778-5784. PMID 1448105 DOI: 10.1128/mcb.12.12.5778  1
1992 Higgins CF, Peltz SW, Jacobson A. Turnover of mRNA in prokaryotes and lower eukaryotes Current Biology. 2: 536. DOI: 10.1016/0960-9822(92)90019-7  0.4
1991 Parker R, Herrick D, Peltz SW, Jacobson A. Measurement of mRNA decay rates in Saccharomyces cerevisiae. Methods in Enzymology. 194: 415-23. PMID 2005800 DOI: 10.1016/0076-6879(91)94032-8  1
1985 Peltz SW, Brown AL, Hasan N, Podhajska AJ, Szybalski W. Thermosensitivity of a DNA recognition site: activity of a truncated nutL antiterminator of coliphage lambda. Science (New York, N.Y.). 228: 91-3. PMID 3156406 DOI: 10.1126/Science.3156406  1
1983 Peltz SW, Katzenellenbogen BS, Kneifel MA, Mangel WF. Plasminogen activators in tissues of the immature and estrogen-stimulated rat uterus and in uterine luminal fluid: characterization and properties Endocrinology. 112: 890-897. PMID 6681601 DOI: 10.1210/Endo-112-3-890  1
1983 Leytus SP, Peltz SW, Mangel WF. Adaptation of acyl-enzyme kinetic theory and an experimental method for evaluating the kinetics of fast-acting, irreversible protease inhibitors Biochimica Et Biophysica Acta (Bba)/Protein Structure and Molecular. 742: 409-418. PMID 6337638 DOI: 10.1016/0167-4838(83)90328-X  1
1982 Liu HY, Peltz SW, Mangel WF. Modulation of the plasminogen activator activity of a transformed cell line by cell density Molecular and Cellular Biology. 2: 1410-1416. PMID 6819454 DOI: 10.1128/Mcb.2.11.1410  1
1982 Peltz SW, Hardt TA, Mangel WF. Positive regulation of activation of plasminogen by urokinase: Differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain α,ω-amino acids Biochemistry. 21: 2798-2804. PMID 6212078 DOI: 10.1021/Bi00540A035  1
1982 Lee Melhado L, Peltz SW, Leytus SP, Mangel WF. p-Guanidinobenzoic acid esters of fluorescein as active-site titrants of serine proteases Journal of the American Chemical Society. 104: 7299-7306. DOI: 10.1002/Chin.198312365  1
1981 Mangel WF, Campbell Livingston D, Brocklehurst JR, Cannon JF, Leytus SP, Peltz SW, Peltz GA, Liu HY. [34] A new active-site titrant of serine proteases Methods in Enzymology. 80: 414-424. PMID 7043196 DOI: 10.1016/S0076-6879(81)80036-5  1
1981 Leytus SP, Peltz GA, Liu HY, Cannon JF, Peltz SW, Livingston DC, Brocklehurst JR, Mangel WF. A quantitative assay for the activation of plasminogen by transformed cells in situ and by urokinase Biochemistry. 20: 4307-4314. PMID 7025895  1
1981 Livingston DC, Brocklehurst JR, Cannon JF, Leytus SP, Wehrly JA, Peltz SW, Peltz GA, Mangel WF. Synthesis and characterization of a new fluorogenic active-site titrant of serine proteases Biochemistry. 20: 4298-4306. PMID 6456760 DOI: 10.1021/Bi00518A010  1
Show low-probability matches.